Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening

被引:12
|
作者
Prefumo, F [1 ]
Thilaganathan, B [1 ]
机构
[1] St George Hosp, Sch Med, Fetal Med Unit, Dept Obstet & Gynaecol, London SW17 ORE, England
关键词
Down syndrome; prenatal screening; nuchal translucency; first trimester; validation;
D O I
10.1002/pd.432
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The agreement between predicted risks of Down syndrome and observed prevalence was investigated in a population of 11847 singleton pregnancies screened by first trimester nuchal translucency at a single institution. Twenty-seven cases of Down syndrome were observed; 20 were detected prenatally by nuchal translucency and maternal age screening, three by other means and four postnatally. The screened women were grouped according to their predicted risk of having an affected pregnancy, and this was compared with the observed prevalence. A significant correlation between predicted and observed prevalences was noted, thus demonstrating that risk estimates for Down syndrome based on first trimester nuchal translucency screening are accurate. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:917 / 918
页数:2
相关论文
共 50 条
  • [32] First trimester screening: Increased nuchal translucency or cystic hygroma?
    Pashaj, Sonila
    Merz, Eberhard
    ULTRASCHALL IN DER MEDIZIN, 2022, 43 (02): : 111 - 114
  • [33] First trimester nuchal translucency screening: Should it be standard of care?
    Malone, FD
    THIRD WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS GYNECOLOGY & INFERTILITY, 2002, : 123 - 125
  • [34] First trimester screening: the genetic implications on nuchal translucency (NT).
    Pergament, E
    DeMarco, K
    Ginsberg, N
    Sabbagha, R
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 671 - 671
  • [35] First-trimester screening for Down syndrome with ductus venosus Doppler studies in addition to nuchal translucency and serum markers
    Borrell, A
    Gonce, A
    Martinez, JM
    Borobio, V
    Fortuny, A
    Coll, O
    Cuckle, H
    PRENATAL DIAGNOSIS, 2005, 25 (10) : 901 - 905
  • [36] Nuchal translucency screening for fetal Down's syndrome
    Dizdarevic, Jadranka
    Izetbegovic, Sebija
    Dekovic, Sanjin
    Stojkanovic, Goran
    HEALTHMED, 2011, 5 (04): : 956 - 959
  • [37] The use of nuchal translucency measurement and second trimester biochemical markers in screening for Down's Syndrome
    Michailidis, GD
    Spencer, K
    Economides, DL
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2001, 108 (10): : 1047 - 1052
  • [38] The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome
    Kadir, RA
    Economides, DL
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1997, 9 (04) : 244 - 247
  • [40] Doubtful association between TAR syndrome and increased nuchal translucency in the first trimester of pregnancy
    Bellver, J
    Lara, C
    Correa, FF
    Serra, V
    PRENATAL DIAGNOSIS, 2006, 26 (04) : 382 - 383